Mode
Text Size
Log in / Sign up

Personalized Feature Statistics framework characterizes genetic variant effects in Alzheimer's Disease across diverse ancestriesGenetic risk for Alzheimer's varies by ancestry in new analysis

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Note that genetic variant effects in Alzheimer's Disease span a spectrum from ancestry-homogeneous to ancestry-dependent effects.

This cohort study utilized ancestrally diverse cohorts within the Alzheimer's Disease Sequencing Project (ADSP). The primary exposure was the Personalized Feature Statistics (PFstatistics) framework. This approach was compared against simulations and traditional treatment of genetic ancestry as a categorical variable. The study aimed to quantify the importance of genetic variants to a phenotype based on each individual's ancestry background.

Main results indicate that Alzheimer's Disease risk variants span a spectrum from ancestry-homogeneous to ancestry-dependent effects. The PFstatistics framework characterizes the spectrum of genetic effects at individual resolution across the ancestry continuum. Distinct selection sets were identified that vary across individuals according to their ancestry background. These outcomes profile heterogeneous genetic effects across the genetic ancestry continuum and support individual-level variant selection with false discovery rate controlled at a target level.

Safety and tolerability data were not reported in this study. A key limitation is that the extent to which the effects of these variants vary across populations of diverse ancestries remains poorly understood. The proposed method is broadly applicable to other heterogeneity features such as environmental factors. This study does not establish causality and findings should be interpreted with caution given the observational nature of the cohort design.

Researchers analyzed data from ancestrally diverse cohorts in the Alzheimer's Disease Sequencing Project to understand how genetic variants affect Alzheimer's disease risk. They used a new framework called Personalized Feature Statistics to look at these effects at an individual level. This approach allowed them to see how genetic risks vary across the spectrum of genetic ancestry rather than treating ancestry as a simple category.

The study found that Alzheimer's risk variants exist on a spectrum from those that work the same across all groups to those that depend on specific ancestry backgrounds. This method also created distinct sets of selected variants that change based on each person's ancestry. These findings help profile how genetic effects are heterogeneous across different populations.

The authors note that how these variant effects vary across diverse populations remains poorly understood. While the proposed method is broadly applicable to other features like environmental factors, the extent of this variation needs more study. This research provides a tool for better understanding individual genetic risks in Alzheimer's disease.

What this means for you:
Genetic Alzheimer's risk varies by ancestry; new method maps this spectrum across diverse populations.

Study Details

Study typeCohort
EvidenceLevel 3
PublishedApr 2026
View Original Abstract ↓
Genome-wide association studies (GWAS) have successfully identified numerous genetic variants associated with complex diseases. However, the extent to which the effects of these variants vary across populations of diverse ancestries remains poorly understood. Furthermore, in these contexts genetic ancestry is treated as a categorical variable, thereby oversimplifying its continuous nature and the more nuanced ways in which it can influence genetic effects on disease. Here, we propose personalized feature statistics (PFstatistics), a statistical framework that quantifies the importance of genetic variants to a phenotype based on each individual's ancestry background, and profiles heterogeneous genetic effects across the genetic ancestry continuum. We demonstrate the utility of this framework through both simulations and real data analysis using sequencing data from ancestrally diverse cohorts in the Alzheimer's Disease Sequencing Project (ADSP). We show that Alzheimer's Disease (AD) risk variants span a spectrum from ancestry-homogeneous to ancestry-dependent effects, and that PFstatistics characterizes this spectrum at individual resolution across the ancestry continuum. PFstatistics also provides individual-level variant selection with FDR controlled at a target level, yielding distinct selection sets that vary across individuals according to their ancestry background. While demonstrated in the context of genetic ancestry, the proposed method is broadly applicable to other heterogeneity features such as environmental factors, offering a robust tool for understanding complex genetic contributions across diverse populations.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.